ABOUT US
General information
Institutional collaborations
Strategy and Funding
Contact
Technology & Business Development Office
Administration
Alumni
Open Science
Science and society
Gender Equality, Diversity and Inclusion (GEDI)
Donate
RESEARCH
Faculty members
Staff Scientists
Faculty Alumni
Research Programmes
Scientific Publications
Projects
Barcelona Collaboratorium
SCIENTIFIC SERVICES
Core Technologies Programme
Scientific resources
European Genome-Phenome Archive
PRBB μFabLab
CAREERS
HR Excellence - HRS4R
Job opportunities
Group Leader Recruitment
Relocation to Barcelona
Career development
Working at CRG
TRAINING
Undergraduates and masters
PhD Students
Postdoctoral Researchers
Courses
TECH TRANSFER
EVENTS
Events
CRG Scientific Sessions
PRBB-CRG Sessions
PRBB Scientific Sessions
Outreach Activities
Courses
NEWS
News
CRG in the Media
Institutional Publications
Search
You are here
You are here:
Home
>
CRG in the media
> 2023
2023
Tweet
2023
21
Jan
Une bactérie tueuse de bactéries pour lutter contre les maladies nosocomiales (Courier Inrternational)
21
Jan
Crean una 'píldora viva' para combatir las infecciones pulmonares resistentes a los antibióticos (Luis Serrano, CRG / Semana)
21
Jan
Crean una 'píldora viva' para combatir las infecciones pulmonares resistentes a los antibióticos (Luis Serrano, CRG / Sport.es)
20
Jan
Researchers engineer bacteria to kill its infectious cousins (CRG / India Today)
20
Jan
Fighting Bacteria with Bacteria: “Living Medicine” Treats Lung Infections (CRG / Geneng News)
20
Jan
Creen una ‘píndola viva’ per a combatre les infeccions pulmonars resistents als antibiòtics (Luis Serrano, CRG / RAC1))
20
Jan
Crean una 'píldora viva' para combatir las infecciones pulmonares resistentes a los antibióticos (Luis Serrano, CRG / La Sexta)
20
Jan
Crean una 'píldora viva' para combatir las infecciones pulmonares resistentes a los antibióticos (Luis Serrano, CRG / Informativos Telecinco)
19
Jan
‘Living medicine’ created to tackle drug-resistant lung infections (CRG / Scienmag)
19
Jan
Newco news: Pulmobiotics is developing cell therapy for lung diseases, but with a twist (BioWorld Financial Watch)
Pages
« first
‹ previous
…
18
19
20
21
22
23
24
25
26
next ›
last »
Archive
2024
(187)
2023
(254)
2022
(321)
2021
(170)
2020
(231)
2019
(331)
2018
(421)
2017
(410)
2016
(515)
2015
(461)
2014
(405)
2013
(464)
2012
(464)
2011
(453)
2010
(347)
2009
(372)
2008
(184)
2007
(24)
2003
(1)